A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

NCT07361302 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1325

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Tenecteplase
DRUG: Standard of care treatment

Sponsor

Boehringer Ingelheim